The company, through its officials, will be participating in a one-to-one meeting with investors. The meeting is scheduled to be held physically on June 12, 2026, in Mumbai.
The interaction will involve a discussion of the company's audited financial results for the year ended March 31, 2026, and a relevant Investor Presentation. Both documents were referenced in a Press Release dated May 26, 2026, and have already been uploaded on the company's website (www.fermentabiotech.com) and on the BSE website (www.bseindia.com).
The company explicitly states that no unpublished price sensitive information (UPSI) is intended to be discussed during this interaction.
The disclosure notes that changes to the meeting schedule may occur due to exigencies on the part of the company or the investors.
The letter was digitally signed by Varadvinayak Vijay Khambete, Company Secretary & Head – Legal (Membership No. A33861), on June 8, 2026, at 17:21:41 IST.